This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
HCA Healthcare (HCA) Q3 Earnings Beat Estimates, Surge Y/Y
by Zacks Equity Research
HCA Healthcare's (HCA) Q3 earnings results reflect gains from patient volumes and better revenues.
Tenet Healthcare (THC) Sees Hammer Chart Pattern: Time to Buy?
by Zacks Equity Research
Tenet Healthcare (THC) has been struggling lately, but the selling pressure may be coming to an end soon.
Tenet Healthcare (THC) Q3 Earnings Beat Mark, Increase Y/Y
by Zacks Equity Research
Tenet Healthcare's (THC) third-quarter earnings results reflect better revenues and higher patient volumes.
Tenet Healthcare (THC) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Tenet (THC) delivered earnings and revenue surprises of 82.57% and 1.39%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Should You Buy Tenet Healthcare (THC) Ahead of Earnings?
by Zacks Equity Research
Tenet Healthcare (THC) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Why Tenet Healthcare (THC) is a Top Growth Stock for the Long-Term
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Tenet Healthcare (THC) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Tenet (THC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
What's in Store for UnitedHealth's (UNH) Earnings in Q3?
by Zacks Equity Research
UnitedHealth's (UNH) Q3 results are likely to report a rise in earnings and revenues.
Down 14.9% in 4 Weeks, Here's Why Tenet (THC) Looks Ripe for a Turnaround
by Zacks Equity Research
Tenet (THC) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
Cigna (CI) Divests Unit to Chubb to Streamline Business
by Zacks Equity Research
Cigna (CI) sells its businesses to Chubb to focus on core growth areas.
Mednax (MD) Invests in Brave Care to Boost Pediatric Business
by Zacks Equity Research
Mednax (MD) and Brave Care form a relationship to provide enhanced pediatric care and pursue its pipeline of pediatric clinics' plan.
UnitedHealth (UNH) Unit Ties Up to Offer Quality Care in Midwest
by Zacks Equity Research
UnitedHealth Group's (UNH) subsidiary Optum collaborates with SSM Health in a bid to employ advanced technologies and insights for delivering better health outcomes across the Midwest.
Teladoc (TDOC) Broadens Accessibility of Primary Care Model
by Zacks Equity Research
Teladoc Health (TDOC) intends to offer enhanced primary care to its members through Primary360, whose reach has now extended to commercial health plans and employers.
Here's Why You Should Retain MEDNAX (MD) in Your Portfolio
by Zacks Equity Research
Riding high on its revenue stream and strategic measures, MEDNAX (MD) holds potential to reap benefits for investors.
Here's Why You Should Buy Acadia Healthcare (ACHC) Stock Now
by Zacks Equity Research
Acadia Healthcare (ACHC) continues to gain from top-line growth, solid demand for behavioral health services, several growth-related initiatives and reducing debt levels.
Is Tenet Healthcare (THC) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
3 Hospital Stocks That Outperformed the S&P Index Year to Date
by Srijita Guha
High patient volumes, mergers and buyouts and demand for virtual health services are likely to help hospital companies like THC, HCA and CYH outperform the S&P Index.
Here's Why You Should Hold Onto Select Medical (SEM) Now
by Zacks Equity Research
Select Medical (SEM) is a long-term player on the back of its leadership position in acute care services.
Tenet Healthcare (THC) Expands Its Relationship With Cigna
by Zacks Equity Research
Tenet Healthcare (THC) stretches multi-year contract with Cigna to provide its in-network access to the latter's customers.
Cigna (CI) Extends Tie-Up to Offer Better Care in Connecticut
by Zacks Equity Research
Cigna (CI) extends relationship with Hartford HealthCare to jointly offer enhanced healthcare services and thus, better health outcomes in Connecticut.
Tenet Healthcare (THC) Hits 52-Week High: More Upside Left? (Revised)
by Zacks Equity Research
Tenet Healthcare's (THC) enhanced portfolio, strategic initiatives and rebounding volumes help it achieve its rally.
Here's Why Tenet Healthcare (THC) is a Strong Growth Stock
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
The Zacks Analyst Blog Highlights: Universal Health Services, Acadia Healthcare Co, HCA Healthcare and Tenet Healthcare
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Universal Health Services, Acadia Healthcare Co, HCA Healthcare and Tenet Healthcare
Tenet Healthcare (THC) Hits 52 Week High: More Upside Left?
by Zacks Equity Research
Tenet Healthcare's (THC) enhanced portfolio, strategic initiatives and rebounding volumes help it aid its upsurge.
4 Hospital Stocks Likely to Perform Well in 2H21
by Debasmita Chatterjee
Companies like UHS, ACHC, HCA and THC are well-poised to gain in the second half of 2021 as the hospital industry is expected to benefit from rebounding admissions and continuous M&A activities.